DCM Shriram Limited (NSE: DCMSHRIRAM) announced consolidated financial results for the second quarter and half year ended September 30, 2026, reporting a consolidated net revenue of ₹3,977 crore, marking a 22% growth over ₹3,272 crore in the corresponding quarter last year. This robust performance was driven by significant contributions from Chemicals & Vinyl, Sugar & Ethanol, Fenesta Building Systems, and Fertilizer businesses.

Chemicals & Vinyl

The Chemicals business saw a 47% revenue growth to ₹1,343 crore, supported by improved ECU realizations and contributions from advanced materials value chain. The commissioning of the Aluminium Chloride plant and partial commissioning of the Calcium Chloride plant at Bharuch further strengthened downstream integration.

Sugar & Ethanol

The Sugar & Ethanol business recorded a 10% revenue increase to ₹1,023 crore, while PBDIT grew 85% to ₹62 crore. Higher domestic sugar prices and improved ethanol margins supported performance, despite lower sugar sales volumes. Ethanol sales volumes increased 24% during the quarter due to a timing difference.

Fenesta Building Systems

Fenesta Building Systems continued its growth momentum, recording revenue of ₹344 crore, up 22%, driven by higher volumes in the Projects vertical. PBDIT increased 15% to ₹49 crore. The commissioning of Phase I of its Aluminium Extrusion Plant at Kota marks a significant milestone in its backward integration strategy.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of DCM Shriram Limited

DCM Shriram Limited belongs to the Industrials › Conglomerates sector. Here’s a quick read on where the business and the stock stand today.

DCM trades in the lower quarter of its 52-week range. Revenue contracts at 5.5% CAGR. That signals structural headwinds, not a short-term blip. The stock gains 2.8% in the last month, recovering from the three-month slide. However, it is too early to call this a confirmed reversal. Revenue grows at 5.5% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of DCM Shriram Limited.

Cyient Limited (CYIENT) announced its financial results for the quarter ended September 30, 2026, showcasing robust performance with revenue up 8.1% QoQ and 15.7% YoY. The EBIT stood at INR 237 crores, marking a 16.8% QoQ growth and a 14.2% EBIT margin.

Revenue and Order Intake

The company’s DET* segment reported revenue at INR 1,664 crores. The Q2 FY27 order intake grew by 20.8% YoY, reflecting strong demand across all key segments.

Profitability and Cash Flow

Cyient DET* PAT reached INR 153 crores, with a QoQ growth of 8.7%. The company also generated INR 214 crores in free cash flow (FCF), with a FCF to PAT conversion rate of 139%.

Sukamal Banerjee, Executive Director and Chief Executive Officer, highlighted the quarter’s achievements, noting the highest-ever Q2 order intake and the successful integration of TAO Digital, which adds depth to the company’s platform software and data engineering capabilities.

Looking ahead, Cyient remains confident in navigating industry headwinds and creating sustainable long-term value for shareholders, driven by strong order books and a maturing pipeline.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Cyient Limited

Cyient Limited belongs to the Industrials › Conglomerates sector. Here’s a quick read on where the business and the stock stand today.

Cyient gains 39.9% over three months and trades near its 52-week highs. Thin margins at 5.0% leave limited room for error — any demand softness or cost spike hits the bottom line hard. Revenue contracts at 6.5% CAGR. That signals structural headwinds, not a short-term blip. The stock trades at 94% of its 52-week range — near its best levels of the year. Clearly, the market pays a premium for this name. The stock rises 39.9% in three months on 6.5% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Cyient Limited.

Cyient Limited (CYIENT) has unveiled its Q2 FY27 investor presentation, highlighting sustained growth and strategic investments. The company reported a 50% QoQ increase in order intake for the custom ASIC business, securing a large engagement with a global semiconductor company. Revenue grew 8% QoQ, marking the 6th consecutive quarter of sequential growth. Margins held steady QoQ, as higher volumes absorbed increased wafer costs and investments in R&D and talent. The order book momentum continued for the 6th consecutive quarter, surpassing the previous quarter’s record, with a strong inflows from large OEMs resulting in a book-to-bill ratio of 1.6x.

Strong Demand Momentum

The company continues to invest in R&D in line with its product strategy. High-voltage power products for AI data centers are on track, and these investments are expected to start translating into revenue in the next fiscal year. Memory shortages may slow near-term growth, but the $100 Mn+ ASIC pipeline supports long-term confidence.

Segment Performance

Growth remained positive across key segments, led by Aerospace and Industrial, with Defense and Medical gaining momentum. The Transportation & Mobility segment saw a 16.5% YoY growth, while Networks & Infrastructure and Strategic Units experienced minor declines. TAO Digital continued to show robust performance.

As Cyient Limited (CYIENT) looks ahead, it remains focused on profitable growth and sustainable margin improvement over the medium to long term.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Cyient Limited

Cyient Limited belongs to the Industrials › Conglomerates sector. Here’s a quick read on where the business and the stock stand today.

Cyient gains 39.9% over three months and trades near its 52-week highs. Thin margins at 5.0% leave limited room for error — any demand softness or cost spike hits the bottom line hard. Revenue contracts at 6.5% CAGR. That signals structural headwinds, not a short-term blip. The stock trades at 94% of its 52-week range — near its best levels of the year. Clearly, the market pays a premium for this name. The stock rises 39.9% in three months on 6.5% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Cyient Limited.